Skip to main content

STIFEL FINANCIAL CORP

Position in LGND — Ligand Pharmaceuticals Inc

CIK 720672 ST. LOUIS, MO

Position in LGND

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$6,591,843
+$3,052,077 QoQ
Shares Held
33,017
+76.4% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 99.4941999575976.ToString("F0")% Shared 0.ToString("F0")% None 0.5058000424023987.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. LGND ranks #12 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,591,843 33,017
2025-12-31 $3,539,766 18,722
2025-09-30 $3,633,494 20,512
2025-06-30 $2,026,914 17,830
2025-03-31 $1,865,182 17,740
2024-12-31 $1,801,512 16,813
2024-09-30 $1,596,333 15,949
2024-06-30 $1,151,075 13,661
2024-03-31 $581,655 7,957
2023-12-31 $513,223 7,186
2023-09-30 $442,388 7,383
2023-06-30 $547,814 7,598
2023-03-31 $324,398 4,410
2020-12-31 $458,039 7,383
2020-09-30 $471,842 7,935
2020-06-30 $506,569 7,260
2020-03-31 $198,153 4,368